Posted in | News | Minerals

Calgon Carbon and ADA-ES Sign MOU to Develop Mercury Emissions Control for Coal-Fired Power Plants

ADA-ES, Inc. and Calgon Carbon Corporation announced that the two companies have executed a Memorandum of Understanding (MOU) to jointly develop products and services for the control of mercury emissions from coal-fired power plants. ADA-ES and Calgon Carbon also intend to explore how existing activated carbon manufacturing facilities should be utilized to satisfy the requirements of this new market and to determine if additional facilities will be needed.

Recent federal and state regulations require the reduction of mercury emissions from coal-fired power plants. Injection of powdered activated carbon into the flue of coal-fired boilers has proven effective in meeting these mercury reduction standards.

"We are excited about the unprecedented combination of experience and resources that we have put together in the team of ADA-ES and Calgon Carbon. Working together, we hope to stay well ahead of the competition and capitalize on the opportunities ADA-ES has created with our investment in mercury control," said Michael Durham, Ph.D, president of ADA-ES. Mr. Durham added, "This relationship should allow us to meet our goal of satisfying both the near-term and long-term mercury control needs of our customers in the power generation market."

Commenting on the announcement, John Stanik, president and chief executive officer of Calgon Carbon, said, "The MOU is the first step in forming a relationship between ADA-ES, a company that has extensive knowledge of this new market and its customers and Calgon Carbon, a leader in activated carbon technology. We are pleased about a potential alliance with ADA-ES, and in the coming months we hope to finalize an agreement between our two companies."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.